Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000937
Chunk: 63

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 63
---
 and between BIODEXA PHARMACEUTICALS PLC, a company incorporated under the laws of England and Wales (the “”), and C/M CAPITAL MASTER FUND, LP,a Delaware limited partnership(together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement
by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time
to time, the “”).

<div align='center'>WHEREAS:</div>

A. Upon
the terms and subject to the conditions of the Purchase Agreement, (i) the Company has agreed to issue to the Investor, and the Investor
has agreed to purchase, up to Thirty-Five Million Dollars ($35,000,000) of the Company’s American Depositary Shares (the “”), each representing 10,000 of the Company’s ordinary shares, nominal value £0.00005 each (the “”), pursuant to the Purchase Agreement (such shares, the “”), and (ii) the Company has
agreed to pay to the Investor a Commitment Fee, or, if not paid in accordance with the Purchase Agreement, issue to the Investor such
number of Depositary Shares as consideration for its commitment to purchase Depositary Shares under the Purchase Agreement at such time
and otherwise in accordance with the terms set forth in of the Purchase Agreement (the “”);
and

B. To
induce the Buyer to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities
Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “”), and applicable state securities laws.

NOW, THEREFORE, in
consideration of the promises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Buyer hereby, intending to be legally bound, agree as follows:

1. .

As used in this Agreement, the
following terms shall have the following meanings:

a. “”
means the Buyer, any transferee or assignee thereof to whom the Buyer assigns its rights under this Agreement in accordance with and who agrees to become bound by the provisions of this Agreement, and any transferee or assignee thereof to whom a transferee
or assignee assigns its rights under this Agreement in accordance with and who agrees to